Ibogaine Therapy: A 'Vast, Uncontrolled Experiment'
Science April 14, 2005 DOI: 10.1126/science.308.5720.345 via OpenAlex
Summary
AI-generated from the abstractAn extract from an African plant, despite its potentially harsh side effects, is currently being tested in two public clinical trials and numerous unregistered or clandestine ones. The extract's use appears to be expanding outside formal research settings, raising concerns about safety and oversight.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Keywords | Clinical trial Internal medicine |
| Citations | 38 |
| Key finding | An African plant extract with potentially harsh side effects is being tested in two public clinical trials and many clandestine ones. |
Abstract
Despite potentially harsh side effects, an African plant extract is being tested in two public clinical trials--and many clandestine ones.